Literature DB >> 31830210

Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma.

Arjun Gupta1, Peiqi Wang2, Syed Abbas Ali1, S Vincent Rajkumar3, Bishal Gyawali4,5, Heidi N Overton2,6, Martin A Makary2,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31830210      PMCID: PMC6990751          DOI: 10.1001/jamaoncol.2019.5426

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

Review 1.  Financial Burden of Drugs Prescribed for Cancer-Associated Symptoms.

Authors:  Arjun Gupta; Leonce Nshuti; Udhayvir S Grewal; Ramy Sedhom; Devon K Check; Helen M Parsons; Anne H Blaes; Beth A Virnig; Maryam B Lustberg; Ishwaria M Subbiah; Ryan D Nipp; Sydney M Dy; Stacie B Dusetzina
Journal:  JCO Oncol Pract       Date:  2021-09-24

2.  Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.

Authors:  Aaron P Mitchell; Akriti Mishra Meza; Katherine S Panageas; Allison Lipitz-Snyderman; Peter B Bach; Michael J Morris
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816

3.  Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare.

Authors:  Kelly E Anderson; Daniel Polsky; Sydney Dy; Aditi P Sen
Journal:  Health Serv Res       Date:  2021-12-14       Impact factor: 3.734

4.  Payment incentives and the use of higher-cost drugs: a retrospective cohort analysis of intravenous iron in the Medicare population.

Authors:  Bryan C Hambley; Kelly E Anderson; Satish P Shanbhag; Aditi P Sen; Gerard Anderson
Journal:  Am J Manag Care       Date:  2020-12       Impact factor: 2.229

5.  Secular Trends in the Pharmacologic Treatment of Osteoporosis and Malignancy-Related Bone Disease from 2009 to 2020.

Authors:  Sara Jane Cromer; Kristin M D'Silva; Elaine W Yu; Joan Landon; Rishi J Desai; Seoyoung C Kim
Journal:  J Gen Intern Med       Date:  2021-06-07       Impact factor: 6.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.